The top 10 biopharma stock gainers and losers for the week.

These graphs compare the performance of the biotech stocks for all of 2025 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Biocomposites, Eyas, Insightec, Mirum, Sonorous Neurovascular.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Apotex, Chemometec, Eisai, Grünenthal, Henlius, Endomimetics, Everest, Factor, Imunon, Liger, Micot, Phase Scientific, Roche, Searchlight, Tempest, Watchmaker, Visby, Vectus, Xortx.

Clinical updates for biopharma and med tech, including data readouts and publications: Aicuris, Alvotech, Ayrmid, Exicure, Pentixapharm.

Biopharma and med-tech companies raising money in public or private financings, including: Angitia, Collplant, GE Medical Holding, Generate, Exact, Inspira, LB, Myndtec.

New hires and promotions in the biopharma and med-tech industries, including: Adarx, Angitia, Braveheart, Calico, Iveena, Polaryx, Primmune, Renovorx, Tempest, Vectory.

Biopharma money raised to-date and by month in 2025, including public, private and other financings.